Skip to Main Content

Paper Details

Cancer-specific mortality in patients with non-metastatic renal cell carcinoma who have undergone a nephrectomy and are eligible for adjuvant pembrolizumab.
Semin Oncol
1
2022
Author NameAffiliation
Fred SaadUniversity of Montreal Health Center
Alberto BrigantiUrological Research Institute, IRCCS San Raffaele Scientific Institute
Markus GraefenMartini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf
  • 1 - 3

Datasets

Release 1.2